Cargando…

Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers

Current studies focus on cellular and humoral immunity induced by novel SARS-CoV-2 vaccines. Non-responders to vaccinations are not uncommonly encountered in clinical medicine (e.g. in the field of hepatitis B). Whereas vaccine-induced humoral immunity against SARS-CoV-2 is compromised by emerging V...

Descripción completa

Detalles Bibliográficos
Autores principales: Krüttgen, Alexander, Klingel, Hanna, Haase, Gerhard, Haefner, Helga, Imöhl, Matthias, Kleines, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452154/
https://www.ncbi.nlm.nih.gov/pubmed/34555429
http://dx.doi.org/10.1016/j.jviromet.2021.114295
_version_ 1784570009763184640
author Krüttgen, Alexander
Klingel, Hanna
Haase, Gerhard
Haefner, Helga
Imöhl, Matthias
Kleines, Michael
author_facet Krüttgen, Alexander
Klingel, Hanna
Haase, Gerhard
Haefner, Helga
Imöhl, Matthias
Kleines, Michael
author_sort Krüttgen, Alexander
collection PubMed
description Current studies focus on cellular and humoral immunity induced by novel SARS-CoV-2 vaccines. Non-responders to vaccinations are not uncommonly encountered in clinical medicine (e.g. in the field of hepatitis B). Whereas vaccine-induced humoral immunity against SARS-CoV-2 is compromised by emerging Variants of Concern (VOCs), cellular immunity against SARS-CoV-2 is emerging as resilient against VOCs. Thus commercially available test kits for diagnostic laboratories designed to evaluate cellular immune responses to SARS-CoV-2 are urgently needed. Here we evaluated the novel QuantiFERON SARS-CoV-2 assay (Qiagen) measuring INF-ɣ release induced by two spike-derived peptide pools (Ag1 and Ag2) in a cohort of health care workers vaccinated with the mRNA-1273 vaccine and confirmed humoral response. Our study indicates the usefulness of this novel assay for routine laboratories to evaluate cellular immunity against SARS-CoV-2 in response to mRNA-1273 vaccination.
format Online
Article
Text
id pubmed-8452154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84521542021-09-21 Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers Krüttgen, Alexander Klingel, Hanna Haase, Gerhard Haefner, Helga Imöhl, Matthias Kleines, Michael J Virol Methods Article Current studies focus on cellular and humoral immunity induced by novel SARS-CoV-2 vaccines. Non-responders to vaccinations are not uncommonly encountered in clinical medicine (e.g. in the field of hepatitis B). Whereas vaccine-induced humoral immunity against SARS-CoV-2 is compromised by emerging Variants of Concern (VOCs), cellular immunity against SARS-CoV-2 is emerging as resilient against VOCs. Thus commercially available test kits for diagnostic laboratories designed to evaluate cellular immune responses to SARS-CoV-2 are urgently needed. Here we evaluated the novel QuantiFERON SARS-CoV-2 assay (Qiagen) measuring INF-ɣ release induced by two spike-derived peptide pools (Ag1 and Ag2) in a cohort of health care workers vaccinated with the mRNA-1273 vaccine and confirmed humoral response. Our study indicates the usefulness of this novel assay for routine laboratories to evaluate cellular immunity against SARS-CoV-2 in response to mRNA-1273 vaccination. Elsevier B.V. 2021-12 2021-09-20 /pmc/articles/PMC8452154/ /pubmed/34555429 http://dx.doi.org/10.1016/j.jviromet.2021.114295 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Krüttgen, Alexander
Klingel, Hanna
Haase, Gerhard
Haefner, Helga
Imöhl, Matthias
Kleines, Michael
Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
title Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
title_full Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
title_fullStr Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
title_full_unstemmed Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
title_short Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
title_sort evaluation of the quantiferon sars-cov-2 interferon-ɣ release assay in mrna-1273 vaccinated health care workers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452154/
https://www.ncbi.nlm.nih.gov/pubmed/34555429
http://dx.doi.org/10.1016/j.jviromet.2021.114295
work_keys_str_mv AT kruttgenalexander evaluationofthequantiferonsarscov2interferonɣreleaseassayinmrna1273vaccinatedhealthcareworkers
AT klingelhanna evaluationofthequantiferonsarscov2interferonɣreleaseassayinmrna1273vaccinatedhealthcareworkers
AT haasegerhard evaluationofthequantiferonsarscov2interferonɣreleaseassayinmrna1273vaccinatedhealthcareworkers
AT haefnerhelga evaluationofthequantiferonsarscov2interferonɣreleaseassayinmrna1273vaccinatedhealthcareworkers
AT imohlmatthias evaluationofthequantiferonsarscov2interferonɣreleaseassayinmrna1273vaccinatedhealthcareworkers
AT kleinesmichael evaluationofthequantiferonsarscov2interferonɣreleaseassayinmrna1273vaccinatedhealthcareworkers